Role of biomarkers in cardiac structure phenotyping in heart failure with preserved ejection fraction: critical appraisal and practical use
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Role of biomarkers in cardiac structure phenotyping in heart failure with preserved ejection fraction: critical appraisal and practical use
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF HEART FAILURE
Volume 17, Issue 12, Pages 1231-1239
Publisher
Wiley
Online
2015-10-24
DOI
10.1002/ejhf.430
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Myocardial Stiffness in Patients With Heart Failure and a Preserved Ejection Fraction: Contributions of Collagen and Titin
- (2015) M. R. Zile et al. CIRCULATION
- Prognostic Impact of Statin Use in Patients With Heart Failure and Preserved Ejection Fraction
- (2015) Kotaro Nochioka et al. CIRCULATION JOURNAL
- Markers of fibrosis, inflammation, and remodeling pathways in heart failure
- (2015) Claudio Passino et al. CLINICA CHIMICA ACTA
- Prognostic value of sST2 added to BNP in acute heart failure with preserved or reduced ejection fraction
- (2015) Fernando Friões et al. Clinical Research in Cardiology
- Prognosis of new-onset heart failure outpatients and collagen biomarkers
- (2015) Laura Sanchis et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- HFpEF vs. HFrEF: can microRNAs advance the diagnosis?
- (2015) Daniela Schmitter et al. EUROPEAN JOURNAL OF HEART FAILURE
- State of the Art: Newer biomarkers in heart failure
- (2015) Rudolf A. de Boer et al. EUROPEAN JOURNAL OF HEART FAILURE
- Circulating microRNAs in heart failure with reduced and preserved left ventricular ejection fraction
- (2015) Lee Lee Wong et al. EUROPEAN JOURNAL OF HEART FAILURE
- Heart failure at the crossroads: moving beyond blaming stakeholders to targeting the heart
- (2015) Michele Senni et al. EUROPEAN JOURNAL OF HEART FAILURE
- MicroRNA signatures differentiate preserved from reduced ejection fraction heart failure
- (2015) Chris J. Watson et al. EUROPEAN JOURNAL OF HEART FAILURE
- The crosstalk between the kidney and the central nervous system: the role of renal nerves in blood pressure regulation
- (2015) Erika E. Nishi et al. EXPERIMENTAL PHYSIOLOGY
- Novel therapeutic targets of metformin: metabolic syndrome and cardiovascular disease
- (2015) Ricardo Ladeiras-Lopes et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- The Path to an Angiotensin Receptor Antagonist-Neprilysin Inhibitor in the Treatment of Heart Failure
- (2015) Eugene Braunwald JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Galectin-3 in Heart Failure With Preserved Ejection Fraction
- (2015) Omar F. AbouEzzeddine et al. JACC-Heart Failure
- Older Adults, “Malignant” Left Ventricular Hypertrophy, and Associated Cardiac-Specific Biomarker Phenotypes to Identify the Differential Risk of New-Onset Reduced Versus Preserved Ejection Fraction Heart Failure
- (2015) Stephen L. Seliger et al. JACC-Heart Failure
- Elevated plasma galectin-3 is associated with near-term rehospitalization in heart failure: A pooled analysis of 3 clinical trials
- (2014) Wouter C. Meijers et al. AMERICAN HEART JOURNAL
- Anti-Inflammatory Effects of Simvastatin in Patients with Chronic Heart Failure
- (2014) T. V. Pinchuk et al. BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE
- METformin in DIastolic Dysfunction of MEtabolic Syndrome (MET-DIME) Trial: Rationale and Study Design
- (2014) Ricardo Ladeiras-Lopes et al. CARDIOVASCULAR DRUGS AND THERAPY
- Clinical Risk Stratification Optimizes Value of Biomarkers to Predict New-Onset Heart Failure in a Community-Based Cohort
- (2014) Frank P. Brouwers et al. Circulation-Heart Failure
- Cardiac Structure and Function and Prognosis in Heart Failure With Preserved Ejection Fraction
- (2014) Amil M. Shah et al. Circulation-Heart Failure
- Elevation in High-Sensitivity Troponin T in Heart Failure and Preserved Ejection Fraction and Influence of Treatment With the Angiotensin Receptor Neprilysin Inhibitor LCZ696
- (2014) Pardeep S. Jhund et al. Circulation-Heart Failure
- Association between renal function and cardiovascular structure and function in heart failure with preserved ejection fraction
- (2014) M. Gori et al. EUROPEAN HEART JOURNAL
- New strategies for heart failure with preserved ejection fraction: the importance of targeted therapies for heart failure phenotypes
- (2014) M. Senni et al. EUROPEAN HEART JOURNAL
- Galectin-3 in patients with heart failure with preserved ejection fraction: results from the Aldo-DHF trial
- (2014) Frank Edelmann et al. EUROPEAN JOURNAL OF HEART FAILURE
- Coronary artery disease and 10-year outcome after hospital admission for heart failure with preserved and with reduced ejection fraction
- (2014) Dan Rusinaru et al. EUROPEAN JOURNAL OF HEART FAILURE
- Elevated Soluble ST2 and Depression Increased the Risk of All-Cause Mortality and Hospitalization in Patients With Heart Failure
- (2014) Su-Dan Xu et al. International Heart Journal
- In-hospital and 1-year outcomes of acute heart failure patients according to presentation (de novo vs. worsening) and ejection fraction. Results from IN-HF Outcome Registry
- (2014) Michele Senni et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- The Global Health and Economic Burden of Hospitalizations for Heart Failure
- (2014) Andrew P. Ambrosy et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Renin-Angiotensin System Blockade and Worsening Renal Function in Heart Failure
- (2014) Marco Metra et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Implications of Coronary Artery Disease in Heart Failure With Preserved Ejection Fraction
- (2014) Seok-Jae Hwang et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Heart Failure Preserved Ejection Fraction With Coronary Artery Disease
- (2014) Barry Greenberg JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Circulating Levels of Tumor Necrosis Factor-Alpha Receptor 2 Are Increased in Heart Failure with Preserved Ejection Fraction Relative to Heart Failure with Reduced Ejection Fraction: Evidence for a Divergence in Pathophysiology
- (2014) Brendan N. Putko et al. PLoS One
- CMR-Verified Diffuse Myocardial Fibrosis Is Associated With Diastolic Dysfunction in HFpEF
- (2014) Mao-Yuan M. Su et al. JACC-Cardiovascular Imaging
- Utility of galectin-3 as a prognostic biomarker in heart failure: where do we stand?
- (2014) Varsha Srivatsan et al. European Journal of Preventive Cardiology
- Novel Biomarkers in Heart Failure with Preserved Ejection Fraction
- (2014) Kevin S. Shah et al. Heart Failure Clinics
- Phenotypic Spectrum of Heart Failure with Preserved Ejection Fraction
- (2014) Sanjiv J. Shah et al. Heart Failure Clinics
- Biomarkers of Myocardial Stress and Fibrosis as Predictors of Mode of Death in Patients With Chronic Heart Failure
- (2014) Tariq Ahmad et al. JACC-Heart Failure
- Developing Therapies for Heart Failure With Preserved Ejection Fraction
- (2014) Javed Butler et al. JACC-Heart Failure
- Prognostic Value of Changes in Galectin-3 Levels Over Time in Patients With Heart Failure
- (2013) A. Rogier van der Velde et al. Circulation-Heart Failure
- Cardiac Structure and Function in Heart Failure With Preserved Ejection Fraction
- (2013) Amil M. Shah et al. Circulation-Heart Failure
- Adrenomedullin in Cardiovascular Disease: A Useful Biomarker, its Pathological Roles and Therapeutic Application
- (2013) Toshio Nishikimi et al. CURRENT PROTEIN & PEPTIDE SCIENCE
- Circulating microRNAs as candidate markers to distinguish heart failure in breathless patients
- (2013) Katrina L. Ellis et al. EUROPEAN JOURNAL OF HEART FAILURE
- Biomarkers of heart failure with normal ejection fraction: a systematic review
- (2013) Jin M. Cheng et al. EUROPEAN JOURNAL OF HEART FAILURE
- Effect of Spironolactone on Diastolic Function and Exercise Capacity in Patients With Heart Failure With Preserved Ejection Fraction
- (2013) Frank Edelmann et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Soluble ST2 as a Biomarker for Detecting Stable Heart Failure With a Normal Ejection Fraction in Hypertensive Patients
- (2013) Yi-Chih Wang et al. JOURNAL OF CARDIAC FAILURE
- Ranolazine in Heart Failure With Preserved Left Ventricular Ejection Fraction and Microvascular Dysfunction: Case Report and Literature Review
- (2013) Emilia D'Elia et al. JOURNAL OF CLINICAL PHARMACOLOGY
- A Novel Paradigm for Heart Failure With Preserved Ejection Fraction
- (2013) Walter J. Paulus et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Biomarkers of Diastolic Dysfunction and Myocardial Fibrosis: Application to Heart Failure with a Preserved Ejection Fraction
- (2013) Michael R. Zile et al. Journal of Cardiovascular Translational Research
- Ranolazine Improves Cardiac Diastolic Dysfunction Through Modulation of Myofilament Calcium Sensitivity
- (2012) Joshua D. Lovelock et al. CIRCULATION RESEARCH
- Comorbidity and Ventricular and Vascular Structure and Function in Heart Failure With Preserved Ejection Fraction
- (2012) Selma F. Mohammed et al. Circulation-Heart Failure
- The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial
- (2012) Scott D Solomon et al. LANCET
- The many faces of heart failure with preserved ejection fraction
- (2012) Amil M. Shah et al. Nature Reviews Cardiology
- Usefulness of Soluble Concentrations of Interleukin Family Member ST2 as Predictor of Mortality in Patients With Acutely Decompensated Heart Failure Relative to Left Ventricular Ejection Fraction
- (2011) Sergio Manzano-Fernández et al. AMERICAN JOURNAL OF CARDIOLOGY
- Prevalence and Significance of Alterations in Cardiac Structure and Function in Patients With Heart Failure and a Preserved Ejection Fraction
- (2011) Michael R. Zile et al. CIRCULATION
- Prognostic Impact of Myocardial Interstitial Fibrosis in Non-Ischemic Heart Failure
- (2011) Tatsuo Aoki et al. CIRCULATION JOURNAL
- Body Mass Index and Adverse Cardiovascular Outcomes in Heart Failure Patients With Preserved Ejection Fraction
- (2011) Markus Haass et al. Circulation-Heart Failure
- Can emerging biomarkers of myocardial remodelling identify asymptomatic hypertensive patients at risk for diastolic dysfunction and diastolic heart failure?
- (2011) Patrick Collier et al. EUROPEAN JOURNAL OF HEART FAILURE
- Ranolazine Improves Angina in Women With Evidence of Myocardial Ischemia But No Obstructive Coronary Artery Disease
- (2011) Puja K. Mehta et al. JACC-Cardiovascular Imaging
- Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction
- (2010) Rudolf A. de Boer et al. ANNALS OF MEDICINE
- Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment
- (2010) B. A. Borlaug et al. EUROPEAN HEART JOURNAL
- ST2: a novel biomarker for heart failure
- (2010) Anju Bhardwaj et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Sympathetic–parasympathetic interaction in health and disease: abnormalities and relevance in heart failure
- (2010) Peter J. Schwartz et al. HEART FAILURE REVIEWS
- Association of Troponin T Detected With a Highly Sensitive Assay and Cardiac Structure and Mortality Risk in the General Population
- (2010) James A. de Lemos et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Chronic Baroreflex Activation: A Potential Therapeutic Approach to Heart Failure With Preserved Ejection Fraction
- (2010) Dimitrios Georgakopoulos et al. JOURNAL OF CARDIAC FAILURE
- Improvement in Left Ventricular Systolic and Diastolic Performance During Ranolazine Treatment in Patients With Stable Angina
- (2010) Vincent M. Figueredo et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- Treatment of Heart Failure With Normal Ejection Fraction
- (2010) Walter J. Paulus et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Ranolazine as a Cardioplegia Additive Improves Recovery of Diastolic Function in Isolated Rat Hearts
- (2009) H. Hwang et al. CIRCULATION
- Episodes of Acute Heart Failure Syndrome Are Associated With Increased Levels of Troponin and Extracellular Matrix Markers
- (2009) Andreia Biolo et al. Circulation-Heart Failure
- Pharmacokinetics and Pharmacodynamics of LCZ696, a Novel Dual-Acting Angiotensin Receptor-Neprilysin Inhibitor (ARNi)
- (2009) Jessie Gu et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Galectins: structure, function and therapeutic potential
- (2008) Ri-Yao Yang et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Irbesartan in Patients with Heart Failure and Preserved Ejection Fraction
- (2008) Barry M. Massie et al. NEW ENGLAND JOURNAL OF MEDICINE
- Diastolic Stiffness of the Failing Diabetic Heart
- (2007) Loek van Heerebeek et al. CIRCULATION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now